Back

Serial biomarker measurements show that down-titration of RAAS inhibitors and up-titration of diuretics mark progression towards end stage heart failure: Analysis of Bio-SHIFT study

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Chronic heart failure (CHF) Pharmacologic therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Milos Brankovic

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

29 More presentations in this session

Presentation thumbnail
Doctor M. Koga (Osaka, JP)
Abstract
Presentation thumbnail
Doctor P. Kanagala (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Associate Professor S. Caravita (Bergamo, IT)
Abstract
Presentation thumbnail
Doctor K. Keramida (Athens, GR)
Abstract Slides
Presentation thumbnail
Professor P. Leszek (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Chronic heart failure (CHF)

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Session
Late-breaking science in acute heart failure
19 May 2025
thumbnail
Congress Presentation
Is downtitration of diuretic therapy safe in patients with heart failure?
20 May 2023
thumbnail
Congress Presentation
Beta-blocker dose titration, functional capacity, and all-cause mortality in patients with heart failure and reduced ejection fraction
29 August 2026
thumbnail
Congress Presentation
Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources